TGFβ Signaling and Cancer
- 10 March 2001
- journal article
- review article
- Published by Elsevier in Experimental Cell Research
- Vol. 264 (1), 111-116
- https://doi.org/10.1006/excr.2000.5140
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- NEW EMBO MEMBERS REVIEW: Transcriptional control by the TGF-beta/Smad signaling systemThe EMBO Journal, 2000
- Regulation of Smad7 Promoter by Direct Association with Smad3 and Smad4Published by Elsevier ,1999
- Differential Inhibition of Smad6 and Smad7 on Bone Morphogenetic Protein- and Activin-mediated Growth Arrest and Apoptosis in B CellsJournal of Biological Chemistry, 1999
- A Smad Transcriptional CorepressorCell, 1999
- Smad7 Is an Activin-inducible Inhibitor of Activin-induced Growth Arrest and Apoptosis in Mouse B CellsPublished by Elsevier ,1998
- Induction of Smad6 mRNA by Bone Morphogenetic ProteinsBiochemical and Biophysical Research Communications, 1998
- Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressorGenes & Development, 1998
- The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ SignalingCell, 1997
- Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15Nature, 1997
- pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrestNature, 1994